OLIX PHARMACEUTICALS, INC. financial statements, including revenue, expenses, profit, and loss

The total revenue of 226950 for the last quarter is 4.60 B KRW, and it's 498.62% higher compared to the previous quarter. The net income of Q2 24 is -9.58 B KRW.